NCT07049653View on ClinicalTrials.gov

Anifrolumab Pregnancy Study

Not yet recruitingOBSERVATIONAL
Enrollment

627

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

December 10, 2030

Study Completion Date

December 10, 2030

Conditions
Systemic Lupus Erythematosus
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

AstraZeneca

INDUSTRY